SCHEMBL6645494

SCHEMBL6645494

Cc1ccc(C(=O)Nc2ccc3c(c2)CCN(Cc2ncn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n2)C3)c(OC(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ PLAU P00749 1/20 0.39
▸ ABCB1 P08183 8/20 0.39
▸ ABCG2 Q9UNQ0 2/20 0.36
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ KCNK3 O14649 1/20 0.35
▸ KCNK9 Q9NPC2 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ TNF P01375 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ NOD2 Q9HC29 2/20 0.35
▸ ACACB O00763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643995 0.83 NOD1 (0.41) NOD1LMNASMN1; SMN2PLAUABCB1
SCHEMBL6645706 0.82 NOD1 (0.38) NOD1LMNASMN1; SMN2PLAUMEN1
SCHEMBL6647009 0.82 PLAU (0.44) NOD1LMNASMN1; SMN2PLAUABCB1
SCHEMBL6648871 0.80 SCN10A (0.37) NOD1LMNASMN1; SMN2PLAUMEN1
SCHEMBL6490283 0.75 NOD1 (0.39) NOD1LMNASMN1; SMN2ABCB1MEN1
SCHEMBL6648762 0.74 SIGMAR1 (0.52) PLAUABCB1ABCG2POLBUSP2
SCHEMBL6649201 0.71 ESR2 (0.52) KCNK3KCNK9NPC1RAB9A
SCHEMBL6646273 0.69 KCNK3 (0.43) KMT2AKCNK3KCNK9NPC1RAB9A
SCHEMBL6648070 0.67 SMN1; SMN2 (0.44) LMNASMN1; SMN2MEN1KMT2AKCNK3
SCHEMBL6645986 0.67 SMN1; SMN2 (0.65) LMNASMN1; SMN2MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR NOD1 850/4885LMNA 1410/4885SMN1; SMN2 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback